West Pharmaceutical Services (WST) Tax Provisions (2009 - 2026)

West Pharmaceutical Services has disclosed Tax Provisions across 18 years of filings, most recently posting $44.7 million for Q1 2026.

• Tax Provisions for Q1 2026 came in at $44.7 million, up 85.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $142.2 million (up 23.44% YoY), and the FY2025 annual result was $121.6 million, up 13.12% from the prior year.
• Tax Provisions came in at $44.7 million for Q1 2026 at West Pharmaceutical Services, up from $33.3 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $44.7 million in Q1 2026 to a low of $16.4 million in Q1 2024.
• The 5-year median for Tax Provisions is $30.2 million (2025), against an average of $30.0 million.
• Across the five-year window, Tax Provisions slumped 37.07% in 2024 and surged 85.48% in 2026, its largest moves.
• West Pharmaceutical Services' Tax Provisions stood at $28.9 million in 2022, then increased by 19.38% to $34.5 million in 2023, then rose by 6.67% to $36.8 million in 2024, then dropped by 9.51% to $33.3 million in 2025, then surged by 34.23% to $44.7 million in 2026.
• The last three Tax Provisions figures came in at $44.7 million (Q1 2026), $33.3 million (Q4 2025), and $34.0 million (Q3 2025), per Business Quant data.